• TRPV1 Modulation Alters Immune Response in Metastatic Breast

  2026-04-30

  This study interrogates how pharmacological modulation of TRPV1 channels in immune cells alters cytokine responses in mice bearing metastatic breast carcinoma. The findings reveal that TRPV1 agonists can paradoxically enhance pro-inflammatory cytokine secretion in tumor-bearing hosts, challenging assumptions about their therapeutic potential in cancer-associated inflammation.

• Kanamycin Sulfate: Precision Control in Microbial Assays

  2026-04-30

  Explore the core scientific advances and best practices for using Kanamycin Sulfate, a water-soluble antibiotic, in demanding microbiology and antibiotic resistance research. This article delivers a uniquely practical, assay-centric perspective informed by landmark studies.

• Transmission and Genetics of Carbapenem Resistance in CREC D

  2026-04-29

  This study systematically characterizes carbapenemase-encoding genes (CEGs) and their transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal the high prevalence, mobility, and clinical impact of multidrug resistance, highlighting the pivotal role of plasmid-borne blaNDM-1 and the importance of molecular surveillance.

• Transmission Dynamics of Carbapenemase Genes in CRE Cloacae

  2026-04-29

  Chen et al. systematically characterized carbapenemase-encoding gene (CEG) distribution and transmission in carbapenem-resistant Enterobacter cloacae from eight hospitals in Guangdong, revealing high rates of blaNDM-1 gene carriage and efficient horizontal gene transfer. These findings clarify resistance mechanisms and inform experimental modeling for antibiotic resistance research.

• Niclosamide in Quantitative Drug Response: STAT3, Viability,

  2026-04-28

  Explore how Niclosamide, a potent STAT3 signaling pathway inhibitor, enables rigorous, quantitative dissection of anti-cancer drug responses. This article uniquely bridges molecular mechanism, advanced viability metrics, and practical protocol optimization.

• Pronase E Protease Mixture: Optimizing Protein Sample Prepar

  2026-04-28

  Pronase E (Activity ≥ 7000 U/g) from APExBIO is a versatile, non-specific protease mixture ideal for robust protein and peptide chain digestion in advanced biochemical workflows. Applied with workflow-driven parameters, it enhances protein sample preparation for demanding proteomics and molecular biology studies.

• p-Cresyl Sulfate: Translational Engine for CKD Cardiovascula

  2026-04-27

  This article synthesizes mechanistic insights and translational strategies around p-Cresyl sulfate (p-tolyl hydrogen sulfate), highlighting its role in endothelial dysfunction, aortic valve calcification, and cardiovascular risk in chronic kidney disease. By integrating recent evidence on the klotho/SIRT1 axis, offering protocol guidance, and positioning APExBIO's p-Cresyl sulfate as a best-in-class research tool, this piece delivers actionable intelligence for translational investigators and distinguishes itself from standard product listings.

• E-64: Precision Cysteine Protease Inhibition in Cell Death R

  2026-04-27

  E-64, a potent L-trans-epoxysuccinyl peptide, enables unparalleled selectivity and efficiency in cysteine protease inhibition—crucial for dissecting lysosomal cell death pathways and cancer mechanisms. This guide presents stepwise protocols, advanced troubleshooting, and actionable insights from the latest research to help you optimize your experimental outcomes.

• In Vitro Activity of Sisomicin vs. Other Aminoglycosides in

  2026-04-26

  This study by Stewart and Bodey rigorously compares the antibacterial activity of sisomicin—a new aminoglycoside at the time—with established agents such as gentamicin, tobramycin, and kanamycin. Their findings reveal sisomicin's enhanced potency against key gram-negative pathogens and delineate the scope and limitations of cross-resistance, informing antibiotic resistance research and guiding the selection of aminoglycoside antibiotics in microbiological workflows.

• G418 Sulfate (Geneticin): Selection and Antiviral Workflows

  2026-04-25

  G418 Sulfate (Geneticin) offers unmatched precision for genetic engineering and antiviral research, enabling robust selection of neomycin-resistant cells and potent inhibition of Dengue virus. This article translates cutting-edge methodology and troubleshooting into actionable protocols, empowering scientists to maximize reliability and efficiency with APExBIO’s ultra-pure G-418 Sulfate.

• AT13387: Redefining Hsp90 Inhibition in Translational Oncolo

  2026-04-24

  This thought-leadership article explores the mechanistic foundations, experimental best practices, and translational promise of AT13387 as a next-generation Hsp90 inhibitor for cancer biology research. By integrating the latest mechanistic insights and cross-linking to key literature, it offers strategic guidance for researchers seeking robust, reproducible data and highlights the critical role of apoptosis and cell cycle modulation in modern oncology workflows.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-04-24

  This study uncovers that enhancing GLT-1 expression in astrocytes attenuates neuronal apoptosis and cognitive deficits after traumatic brain injury (TBI) by suppressing the CB1-CREB signaling axis. The findings highlight a mechanistic link between endocannabinoid signaling, astrocytic glutamate transport, and neuroprotection, suggesting new intervention targets for TBI.

• COX-2 Pathway Modulation in Muscle Ischemia Post-Venom Injur

  2026-04-23

  This study uncovers the temporal dual role of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle recovery after Bothrops asper venom-induced injury. Early COX-2 inhibition worsens ischemia, but later enhances angiogenic signaling, offering new insight into the timing of selective COX-2 inhibitor use in tissue regeneration models.

• Gentamycin Sulfate in Advanced Bacterial Protein Synthesis R

  2026-04-23

  Gentamycin Sulfate empowers researchers to unravel mechanisms of antibiotic resistance and ribosome function in Gram-negative pathogens. This guide delivers actionable workflows, protocol refinements, and troubleshooting strategies inspired by the latest multidrug-resistance transmission studies.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-04-22

  This study demonstrates that CX-5461, a selective RNA polymerase I inhibitor, suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, and enhances cisplatin sensitivity. The findings highlight a mechanistically distinct pathway for targeting ribosome biogenesis in cervical cancer, offering new avenues for overcoming chemoresistance.

16754 records 1/1117 page Next 12345 下5页 Last page